title: Barriers and challenges in integration of anthroposophic medicine in supportive breast cancer care.
abstract: In the last decade, more and more oncology centers are challenged with complementary medicine (CM) integration within supportive breast cancer care. Quality of life (QOL) improvement and attenuation of oncology treatment side effects are the core objectives of integrative CM programs in cancer care. Yet, limited research is available on the use of specific CM modalities in an integrative setting and on cancer patients' compliance with CM consultation. Studies are especially warranted to view the clinical application of researched CM modalities, such as anthroposophic medicine (AM), a unique CM modality oriented to cancer supportive care. Our objective was to characterize consultation patterns provided by physicians trained in CM following oncology health-care practitioners' referral of patients receiving chemotherapy. We aimed to identify characteristics of patients who consulted with AM and to explore patients' compliance to AM treatment. Of the 341 patients consulted with integrative physicians, 138 were diagnosed with breast cancer. Following integrative physician consultation, 56 patients were advised about AM treatment and 285 about other CM modalities. Logistic multivariate regression model found that, compared with patients receiving non-anthroposophic CM, the AM group had significantly greater rates of previous CM use [EXP(B) = 3.25, 95% C.I. 1.64-6.29, p = 0.001] and higher rates of cancer recurrence at baseline (p = 0.038). Most AM users (71.4%) used a single AM modality, such as mistletoe (viscum album) injections, oral AM supplements, or music therapy. Compliance with AM modalities following physician recommendation ranged from 44% to 71% of patients. We conclude that AM treatment provided within the integrative oncology setting is feasible based on compliance assessment. Other studies are warranted to explore the effectiveness of AM in improving patients' QOL during chemotherapy.
authors: Integrative Oncology Program, Oncology Service, Lin Medical Center, Clalit Health Services, Haifa and Western Galilee District, 35 Rothschild St, Haifa, 35152 Israel ; Department of Family Medicine, Faculty of Medicine, Complementary and Traditional Medicine Unit, Technion-Israel Institute of Technology, Haifa, Israel.
authors: Eran
authors: E
authors: Ben-Arye
authors: Elad
authors: E
authors: Schiff
authors: Moti
authors: M
authors: Levy
authors: Orit Gressel
authors: OG
authors: Raz
authors: Yael
authors: Y
authors: Barak
authors: Gil
authors: G
authors: Bar-Sela
keywords: Anthroposophic medicine; Cancer; Complementary medicine; Integrative medicine; Quality of life; Viscum album
references: Psychooncology. 2007 Nov;16(11):980-4
references: 17351987
references: Anticancer Res. 2002 May-Jun;22(3):1399-407
references: 12168816
references: Patient Educ Couns. 2012 Dec;89(3):423-9
references: 22401792
references: Phytochemistry. 2001 Oct;58(4):567-9
references: 11576599
references: BMC Cancer. 2009 Dec 18;9:451
references: 20021637
references: Int J Gynecol Cancer. 2012 Jan;22(1):146-53
references: 21912265
references: BMC Complement Altern Med. 2011 Aug 28;11:72
references: 21871125
references: Anticancer Res. 2006 Jan-Feb;26(1B):709-13
references: 16739342
references: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003297
references: 18425885
references: Integr Cancer Ther. 2012 Jun;11(2):90-100
references: 21733987
references: Forsch Komplementmed. 2006 Jun;13(3):156-66
references: 16868361
references: Integr Cancer Ther. 2013 Jul;12(4):301-11
references: 23264335
references: Anticancer Res. 2005 Nov-Dec;25(6C):4753-7
references: 16334172
references: Support Care Cancer. 2006 Feb;14(2):147-52
references: 16133071
references: Med Oncol. 2013 Jun;30(2):511
references: 23435989
references: BMC Complement Altern Med. 2012 Oct 03;12:172
references: 23033982
references: Phytomedicine. 2011 Jan 15;18(2-3):151-7
references: 20724129
references: Arzneimittelforschung. 2005;55(1):38-49
references: 15727163
references: Oncology. 2011;80(1-2):29-33
references: 21606661
references: Phytother Res. 2002 Mar;16(2):143-7
references: 11933116
references: Eur J Surg Oncol. 2012 Feb;38(2):110-7
references: 22172646
references: Anticancer Res. 2004 Jan-Feb;24(1):303-9
references: 15015612
references: Arzneimittelforschung. 2006 Jun;56(6A):483-96
references: 16927530
references: Anticancer Res. 2006 Mar-Apr;26(2B):1519-29
references: 16619567
references: Integr Cancer Ther. 2010 Jun;9(2):142-57
references: 20483874
references: Forsch Komplementmed. 2008 Feb;15(1):22-30
references: 18334811
references: J Exp Clin Cancer Res. 2009 Jun 11;28:79
references: 19519890
references: Cancer. 2000 Aug 15;89(4):873-80
references: 10951352